SPONSORED CONTENT Across America, safety-net hospitals stand as a lifeline for millions. These institutions serve patients who often have nowhere […]
SPONSORED CONTENT The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims […]
SPONSORED CONTENT News of an electronic medical record (EMR) conversion often brings about palpable anxiety and anticipation as a covered […]
SPONSORED CONTENT As we endure Spring 2025, many covered entities (CEs) continue to perform their ordinary and necessary duties to […]
SPONSORED CONTENT The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in […]
SPONSORED CONTENT Please join on us April 22nd at 1:00 p.m. EST for the third installment of RxParadigm’s 340B Clearinghouse […]
SPONSORED CONTENT It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an […]
SPONSORED CONTENT At the 340B Coalition winter conference in February, two major topics were impossible to ignore: the growing interest […]
SPONSORED CONTENT W. Edwards Deming is a renowned statistician and expert in quality management. He is often quoted as saying, […]
SPONSORED CONTENT The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is […]